Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of AGXT2L1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | affects expression | ISO | Etnppl (Rattus norvegicus) | 6480464 | Estradiol affects the expression of ETNPPL mRNA | CTD | PMID:32145629 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ETNPPL mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ETNPPL mRNA | CTD | PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ETNPPL mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ETNPPL mRNA | CTD | PMID:21632981 | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of ETNPPL mRNA | CTD | PMID:18648102 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Etnppl (Rattus norvegicus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of ETNPPL mRNA | CTD | PMID:30723492 | 8-Br-cAMP | increases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ETNPPL mRNA | CTD | PMID:22079614 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ETNPPL mRNA | CTD | PMID:35032568 | aflatoxin B1 | affects expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of ETNPPL protein | CTD | PMID:20106945 | aflatoxin B1 | decreases methylation | ISO | ETNPPL (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ETNPPL gene | CTD | PMID:27153756 | aflatoxin B1 | decreases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of ETNPPL mRNA | CTD | PMID:22100608 and PMID:27153756 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ETNPPL mRNA | CTD | PMID:19770486 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ETNPPL mRNA | CTD | PMID:19770486 | benzo[a]pyrene | decreases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ETNPPL mRNA | CTD | PMID:32234424 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of AGXT2L1 exon and Benzo(a)pyrene results in decreased methylation of AGXT2L1 intron | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | ETNPPL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of AGXT2L1 exon and Benzo(a)pyrene results in increased methylation of AGXT2L1 promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | ETNPPL (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ETNPPL 3' UTR | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | Etnppl (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ETNPPL mRNA | CTD | PMID:25181051 and PMID:32145629 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of AGXT2L1 promoter | CTD | PMID:27312807 | bromobenzene | increases expression | ISO | Etnppl (Rattus norvegicus) | 6480464 | bromobenzene results in increased expression of ETNPPL mRNA | CTD | PMID:32479839 | butanal | increases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of ETNPPL mRNA | CTD | PMID:26079696 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | CGP 52608 | multiple interactions | ISO | ETNPPL (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to AGXT2L1 gene] | CTD | PMID:28238834 | choline | multiple interactions | EXP | | 6480464 | [Dietary Fats co-treated with Choline deficiency] results in decreased expression of ETNPPL mRNA and PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in decreased expression of ETNPPL mRNA] | CTD | PMID:29246445 | copper(II) sulfate | decreases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ETNPPL mRNA | CTD | PMID:19549813 | Cuprizon | decreases expression | ISO | Etnppl (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of ETNPPL mRNA | CTD | PMID:26577399 | Cuprizon | increases expression | ISO | Etnppl (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of ETNPPL mRNA | CTD | PMID:27523638 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ETNPPL mRNA | CTD | PMID:19770486 | cyclosporin A | decreases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ETNPPL mRNA | CTD | PMID:20106945 more ... | cyproconazole | decreases expression | EXP | | 6480464 | cyproconazole results in decreased expression of ETNPPL mRNA | CTD | PMID:22334560 | diclofenac | decreases expression | EXP | | 6480464 | Diclofenac results in decreased expression of ETNPPL mRNA | CTD | PMID:26934552 | dicrotophos | decreases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of ETNPPL mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | ETNPPL (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | ISO | Etnppl (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of ETNPPL mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | entinostat results in increased expression of ETNPPL mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | ETNPPL (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ETNPPL mRNA | CTD | PMID:27188386 | epoxiconazole | decreases expression | EXP | | 6480464 | epoxiconazole results in decreased expression of ETNPPL mRNA | CTD | PMID:22334560 | ethanol | affects expression | EXP | | 6480464 | Ethanol affects the expression of ETNPPL mRNA | CTD | PMID:30319688 | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of ETNPPL mRNA | CTD | PMID:30319688 | fenthion | increases expression | EXP | | 6480464 | Fenthion results in increased expression of ETNPPL mRNA | CTD | PMID:34813904 | GW 4064 | increases expression | EXP | | 6480464 | GW 4064 results in increased expression of ETNPPL mRNA | CTD | PMID:26655953 | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ETNPPL mRNA | CTD | PMID:36331819 | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of ETNPPL mRNA | CTD | PMID:27339419 | N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of ETNPPL mRNA | CTD | PMID:24535843 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of ETNPPL mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | Etnppl (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of ETNPPL mRNA | CTD | PMID:32479839 | paracetamol | multiple interactions | EXP | | 6480464 | PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of ETNPPL mRNA] | CTD | PMID:29246445 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ETNPPL mRNA | CTD | PMID:29246445 | paracetamol | decreases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of ETNPPL mRNA | CTD | PMID:21420995 and PMID:29067470 | PCB138 | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ETNPPL mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ETNPPL mRNA | CTD | PMID:36331819 | phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ETNPPL mRNA] | CTD | PMID:19482888 | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of ETNPPL mRNA | CTD | PMID:19270015 more ... | pirinixic acid | multiple interactions | ISO | ETNPPL (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ETNPPL mRNA | CTD | PMID:19710929 | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of ETNPPL mRNA | CTD | PMID:20813756 and PMID:23811191 | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of ETNPPL mRNA | CTD | PMID:27413110 | propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of ETNPPL mRNA | CTD | PMID:21278054 and PMID:22334560 | quercetin | decreases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ETNPPL mRNA | CTD | PMID:21632981 | quinolin-8-ol | decreases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Oxyquinoline results in decreased expression of ETNPPL mRNA | CTD | PMID:21632981 | rifampicin | increases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Rifampin results in increased expression of ETNPPL mRNA | CTD | PMID:24552687 | SB 431542 | multiple interactions | ISO | ETNPPL (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | senecionine | increases expression | EXP | | 6480464 | senecionine results in increased expression of ETNPPL protein | CTD | PMID:35357534 | sodium arsenite | decreases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ETNPPL mRNA | CTD | PMID:29301061 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ETNPPL mRNA | CTD | PMID:37682722 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of ETNPPL mRNA | CTD | PMID:33933676 | sulforaphane | decreases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of ETNPPL mRNA | CTD | PMID:31838189 | sulindac sulfide | increases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | sulindac sulfide results in increased expression of ETNPPL mRNA | CTD | PMID:12734198 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of ETNPPL mRNA | CTD | PMID:27339419 and PMID:31919559 | thioacetamide | decreases expression | ISO | Etnppl (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of ETNPPL mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of ETNPPL mRNA | CTD | PMID:29264374 | trichostatin A | increases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | trichostatin A results in increased expression of ETNPPL mRNA | CTD | PMID:24935251 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of ETNPPL mRNA | CTD | PMID:28973697 | valproic acid | affects expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ETNPPL mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | ETNPPL (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ETNPPL mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | ETNPPL (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ETNPPL mRNA | CTD | PMID:27188386 | |